Category: Diabetic Foot

Limb-Sparing Surgery in the Diabetic Foot: A Modern Surgical Strategy

Written by: Athena Kapralou

Overview

Limb-sparing surgery in the diabetic foot represents a modern surgical strategy aimed at controlling infection, removing non-viable soft tissue or bone, and preserving as much functional foot structure as possible, while avoiding major amputation whenever it is safe to do so.

In patients with diabetic foot infection, diabetic foot osteomyelitis, and chronic limb-threatening ischaemia, limb-sparing surgery is not performed in isolation. It is part of a structured, multidisciplinary limb-salvage approach that combines systemic antibiotics, vascular assessment and revascularisation, pressure off-loading, wound care, and rehabilitation.

Principles of Limb-Sparing Surgery

The core principle of limb-sparing surgery is to eradicate infection and remove non-viable, ischaemic tissue while preserving a stable, plantigrade, and functional foot that can support mobility and walking.

Current guidance recommends urgent surgical assessment in cases of severe infection, gangrene, deep abscess, necrotising infection, compartment involvement, or severe ischaemia. Delayed intervention increases tissue loss and can threaten both the limb and the patient’s life.

In practice, limb-sparing surgery depends on three key conditions: adequate perfusion, sufficient viable soft tissue for coverage, and the ability to remove infected or ischaemic tissue without compromising the overall function of the foot or limb.

Peripheral arterial disease is a major determinant of failure. For this reason, vascular assessment—and when necessary, endovascular or open revascularisation—is a central part of treatment planning.

Infection Control in Limb-Sparing Surgery

Debridement and Drainage

A key first step in limb-sparing surgery is the urgent control of infection through drainage of abscesses and debridement of necrotic or infected tissue. Early surgical intervention, often within 24–48 hours, is recommended in moderate to severe diabetic foot infections when infected tissue must be removed.

Thorough soft-tissue debridement reduces bacterial load, allows accurate assessment of the extent of disease, and prepares the wound for further procedures or definitive closure.

Bone Resection and Conservative Surgery

When osteomyelitis is present, limb-sparing surgery focuses on targeted bone resection, aiming to remove infected bone while preserving as much of the foot architecture as possible.

This may include local excision, sequestrectomy, partial ostectomy, or limited resection of the affected ray or metatarsal. These procedures are typically combined with antibiotic therapy tailored to microbiological findings and the extent of residual disease.

Ischaemia, Revascularisation, and Limb-Sparing Surgery

Critical limb ischaemia and chronic limb-threatening ischaemia are common in patients with diabetic foot ulcers and play a central role in wound healing and amputation risk.

In the context of limb-sparing surgery, restoration of blood flow is often essential. Revascularisation—either endovascular or surgical—is considered a prerequisite for wound healing and for performing safe debridement or limited, limb-sparing amputations in ischaemic limbs.

Current vascular and diabetic foot guidelines emphasise that major amputation should not be performed in patients with critical limb ischaemia until all options for revascularisation have been evaluated by a multidisciplinary vascular team, except in life-threatening situations such as overwhelming sepsis, wet gangrene, or a completely non-viable foot.

When successful, revascularisation allows more distal, limb-sparing procedures, avoiding primary below-knee amputation and preserving function. In contrast, failed or non-feasible revascularisation is strongly associated with poor healing, re-amputation, and eventual limb loss.

Minor Amputations in Limb-Sparing Surgery

Minor amputations are an integral part of limb-sparing surgery and are performed below the ankle. These include toe, ray, transmetatarsal, Lisfranc, and Chopart amputations, when these levels allow complete infection control and adequate healing.

Their goal is not simply to remove diseased tissue, but to preserve foot length, balance, and the ability to walk, whenever a stable and functional residual foot can be achieved.

In ischaemic limbs with localised gangrene, minor amputation following successful revascularisation can remove non-viable tissue while maintaining a functional foot segment. In contrast, in cases of extensive tissue loss, non-reconstructable ischaemia, or a non-functional residual foot, primary major amputation may be the safer and more appropriate option.

Evidence for Outcomes in Limb-Sparing Surgery

Published data support the effectiveness of limb-sparing surgery in selected patients with diabetic foot osteomyelitis and ischaemic diabetic foot.

In one cohort of 50 patients with diabetic foot osteomyelitis, limb salvage was achieved in 47 patients (94%), with only 3 patients requiring below-knee amputation after initial limb-sparing management combining debridement or limited amputation with antimicrobial therapy.

In a subsequent series of below-ankle limb-sparing surgery for osteomyelitis, 59% of cases were in remission at one year, supporting the feasibility of this approach in carefully selected patients.

In ischaemic diabetic foot ulcers caused by below-the-ankle arterial disease, revascularisation within a structured limb-salvage pathway significantly reduced the risk of non-healing, as well as both minor and major amputation.

Even in so-called “no-option” critical limb ischaemia, conservative limb-sparing strategies have achieved limb salvage in approximately one-third of patients and have been associated with improved one-year survival.

When Is Limb-Sparing Surgery Appropriate?

Limb-sparing surgery is most appropriate when infection and/or ischaemic tissue can be completely removed at a limited level, the remaining tissues are viable, and perfusion is adequate or can be restored through revascularisation.

This approach is particularly effective in forefoot disease, where removal of infected bone, localised gangrene, or limited amputation can still preserve a stable, weight-bearing foot.

However, limb preservation is not always possible or advisable. In cases of extensive hindfoot destruction, uncontrolled necrotising infection, non-reconstructable ischaemia, or a non-functional residual limb, major amputation may represent the safer and more predictable option for both survival and long-term mobility.

Multidisciplinary care

Successful limb salvage requires more than the operation itself. Optimal outcomes depend on coordinated glycaemic control, microbiological sampling, antibiotic therapy, vascular input and revascularisation, biomechanical off-loading, wound closure planning, and long-term surveillance to reduce recurrence and re-ulceration. A structured limb-salvage pathway, integrating revascularisation, staged debridement or minor amputation, advanced wound care, and custom footwear, has been associated with lower rates of major amputation and improved survival compared with unstructured care.

Clinical message

Limb-sparing procedures are now a central part of modern diabetic foot surgery in both infected and ischaemic limbs. When combined with early infection control, restoration of blood flow, targeted antibiotics, and structured follow-up, they can preserve mobility and avoid major amputation in many appropriately selected patients.

References

  1. Lipsky BA, Aragón-Sánchez J, Diggle M, Embil J, Kono S, Lavery LA, et al. IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections. Clin Infect Dis. 2024.

  2. Hinchliffe RJ, Forsythe RO, Apelqvist J, Boyko EJ, Fitridge R, Hong JP, et al. IWGDF guidelines on diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers and diabetes. Diabetes Metab Res Rev. 2020;36(S1):e3276.

  3. Abu-Qamar F, Soni A, Malik RA. Amputation in diabetic foot ulcer: a treatment dilemma. World J Diabetes. 2023;14(5):560–575.

  4. Meloni M, Izzo V, Morosetti D, Giurato L, Uccioli L. Chronic limb-threatening ischemia in patients with type 2 diabetes: epidemiology, pathophysiology and management. J Clin Med. 2023;12(15):4821.

  5. O’Neal L, Johnson J, Zgonis T, et al. Outcomes of limb-sparing surgery for osteomyelitis in the diabetic foot. Open Forum Infect Dis. 2019;6(10).

  6. Spillerova K, Mazzolai L, Haine A, Teraa M, Vermassen F, Venermo M, et al. Limb salvage in diabetic patients with no-option critical limb ischaemia. Int J Low Extrem Wounds. 2019;18(3):250–258.

  7. Vasukutty et al. Limb salvage surgery in diabetic foot infection: encouraging early results with local antibiotic carrier. Diabetic Foot J. 2022;25(2).

  8. Peterlin AAN, Jensen LK, Gleipner-Andersen E, Gottlieb H. CLOSE-UP – a favourable protocol for limb-sparing surgery of diabetic foot osteomyelitis. J Bone Jt Infect. 2025 Jun 16;10(3):199-206. doi: 10.5194/jbji-10-199-2025. PMID: 40538621; PMCID: PMC12177510.

  9. [Author(s)]. Limb salvage and prevention of ulcer recurrence in a chronic diabetic foot: a case-based approach. [Journal]. 2020;xx(x):xx–xx.

  10. Ferraresi R, Ferlini M, Da Ros R, et al. Overcoming ischaemia in the diabetic foot: minimally invasive techniques. Vasa. 2021;50(6):403–412.

  11. Miyajima S, Shirai A, Yamamoto S, et al. Revascularization surgery: its efficacy for limb salvage in diabetic patients with critical limb ischaemia. Ann Vasc Dis. 2016;9(1):15–21.

  12. Schaper NC, Netten JJ van, Apelqvist J, Bus SA, Hinchliffe RJ, Lipsky BA. Treatment of the diabetic foot – to amputate or not? Vasc Health Risk Manag. 2014;10:671–679.

  13. Husakova J. et al. Factors influencing the risk of major amputation in patients with chronic limb-threatening ischemia and diabetic foot ulcers after advanced therapies. J Clin Med. 2022;11(7):xxxx.

  14. Gambardella et al. Diabetic limb salvage: surgeon’s perspective. Lower Extremity Rev. 2013;5(4).

  15. Frykberg RG, Attinger C, Smeets L, Koller A, Bal A, Kavarthapu V. Surgical strategies for prevention of amputation of the diabetic foot. J Clin Orthop Trauma. 2021 Feb 26;17:99-105. doi: 10.1016/j.jcot.2021.02.019. PMID: 33738238; PMCID: PMC7944028.

Share this post:

Leave the first comment

Related Post

Join the Vagus Sx Clinical Trial: Pioneering a New Treatment for Type 2 Diabetes!

Latest Post

Or, stay updated via our RSS feed!